gemcitabine has been researched along with Anemia, Hemolytic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bain, BJ; Erblich, T; Hill, PD; Tomlinson, J | 1 |
Courtellemont, C; Esposito, L; Guitard, J; Kamar, N; Mehrenberger, M; Modesto, A; Pontier, S; Ribes, D; Rostaing, L | 1 |
Caca, K; Helmchen, U; Schmidt, A; Schwella, N; von Renteln, D | 1 |
3 other study(ies) available for gemcitabine and Anemia, Hemolytic
Article | Year |
---|---|
The complex morphology of acute kidney injury with microangiopathic hemolytic anemia and hyposplenism.
Topics: Acute Kidney Injury; Adenocarcinoma, Mucinous; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Blood Cells; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Microscopy; Middle Aged; Pancreatic Neoplasms; Splenectomy | 2015 |
Thrombotic microangiopathy in a sirolimus-treated renal transplant patient receiving gemcitabine for lung cancer.
Topics: Anemia, Hemolytic; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Middle Aged; Sirolimus; Thrombocytopenia | 2007 |
[A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].
Topics: Adrenal Cortex Neoplasms; Adult; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Biopsy; Blindness; Deoxycytidine; Diagnosis, Differential; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension, Malignant; Kidney; Male; Purpura, Thrombotic Thrombocytopenic | 2008 |